Cammic injection 500mg/5ml Vinphaco treatment and prevention of bleeding (10 blisters x 5 tubes x 5ml)

Dosage form Box of 10 blisters x 5 tubes x 5ml
Specifications Tranexamic acid
Ingredient Hemorrhage, multiple menstruation, hemolysis due to tuberculosis, renal bleeding, nose bleeding

Ingredient

Composition information	Content
Tranexamic acid	500

Uses

indications

Cammic medicine is indicated in the following cases:

Treatment and prevention of bleeding in combination with increased decomposition of fibrin. thrombosis.

Therefore can use tranexamic acid to treat fibrin bleeding diseases that can occur in many clinical situations including multiple trauma and blood clots.

Pharmacokinetics

absorption

Use the provincial injection pulse to reach the maximum concentration immediately and decrease all after 6 hours. After intravenous intravenous injection, there is a half -life of about 2 hours.

Distribution

Sugar drugs are distributed to all tissues, to brainch ohydratic fluids slower, distribution is 33% of body weight.

Elimination

more than 95% of intravenous dose excreted in the form of unchanged urine. Redicular renal function easily causes tranexamic acid accumulation.

Before taking Cammic injection 500mg/5ml Vinphaco treatment and prevention of bleeding (10 blisters x 5 tubes x 5ml)

How to use

Use intravenously.

Dosage

Usual dose

500 - 1000 mg or 10 - 15 mg/kg body weight 2-3 times/24 hours. Slow intravenous injection, not faster than 2 ml/min.

Body fibrin decomposition

1000 mg/time, intravenous injection 3-4 times/24 hours. Slow intravenous injection, not faster than 2 ml/min.

Prostate removal tips

500 - 1000 mg/time, intravenous injection, not faster than 2 ml/min, 2-3 times/24 hours, the first dose used during surgery, the next dose used in the first 3 days after surgery. Then switch to oral.

People with severe kidney failure, need to adjust the dose of tranexamic acid as follows:

Creatinine concentration in nanomol/ml (nmol/ml) or micromol/liter

Intravenous dose of tranexamic acid

120 - 249

10 mg/kg body weight, 2 times/24 hours.

250 - 500

10 mg/kg body weight, 1 time/24 hours.

500

5 mg/kg body weight, 2 times/24 hours.

Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose?

Symptoms of overdose may be: nausea, vomiting, symptoms and/or hypotension. There is no special measure to treat tranexamic acid poisoning.

If the poisoning is overdose, causing vomiting, gastric lavage and active carbon. In both cases of oral and infusion, it is advisable to maintain additional fluid to promote the excretion of the kidneys and use symptomatic treatments and support treatment.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Cammic medicine, you may experience unwanted effects (ADR).

Common, ADR> 1/100

Dosage disorders related to the dose: nausea, vomiting, diarrhea.

Systemic: dizziness.

Uncommon, 1/1000

Circulation: Hypotension after intravenous injection.

Rare, ADR

Eye: Change color awareness.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Cammic drugs contraindicated in the following cases:

Hypersensitivity to tranexamic acid.

There is a history of thrombosis.

Cases of central nervous system surgery, central nervous system bleeding and subarachnom bleeding or other cases of brain bleeding.

Caution when using

Person of kidney failure: Due to the risk of accumulation of tranexamic acid.

People with urinary hemorrhage from the upper urinary tract, are at risk of being blocked in the kidneys.

People with a history of thrombosis should not use Tranexamic acid unless they are treated with anticoagulants. Bleeding due to scattered blood clotting is not treated with anti -decomposition drugs unless the disease is mainly due to fibrin decomposition mechanism disorders. In the case of fibrin decomposition is associated with increased blood clotting (pepper syndrome or fibrin decomposition), it is necessary to add anticoagulant such as heparin with carefully considered dosage. Consider the need to use thrombin III resistant for patients who consume blood clotting factors, otherwise, the deficiency of thrombin III resistant can hinder the effects of heparin.

The ability to drive and operate machinery

No report.

Pregnancy

should not use tranexamic acid during the first months of pregnancy, because there is a notice of the teratogenic effect on experimental animals. Clinical experience in treatment with Tranexamic acid for pregnant women is very limited, so far experimental or clinical data shows no increased risk when taking the drug. Documents about using tranexamic acid for pregnant women are very small, so they only use drugs during pregnancy when they are strictly indicated and when they cannot be used for other treatments.

Lactation period

tranexamic acid secreted into breast milk but the risk of side effects for children is unlikely to occur when using normal doses, so can use tranexamic acid at normal doses, when needed for nursing mothers.

Medicinal interaction

should not be used simultaneously with tranexamic acid with estrogen because it can cause more thrombosis.

Be cautious when using Tranexamic Acid with other hemostasis.

Storage

In a cool dry place, avoid light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.